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Jordan T Glicksman1, Jason H Franklin1, Jessica Shepherd2 and Brian W Rotenberg1,3*Abstract
Objectives: Papillary seromucinous adenocarcinoma of the sinonasal tract is exceedingly rare. The objectives of this
case report are to describe a case of papillary seromucinous adenocarcinoma presenting in the nasopharynx and to
review the literature pertaining to other similar cases.
Methods: A review of the patient's chart and a review of the English literature were conducted.
Results: We describe the case of a 64 year-old woman who presented with a 3-year history of epistaxis and
right-sided otitis media with effusion. The patient had been followed for a known nasopharyngeal mass that had
twice been biopsied and in both cases was considered a benign mass pathologically. A third biopsy was diagnosed
as a low-grade papillary seromucinous adenocarcinoma. The patient was otherwise asymptomatic. The patient was
referred to a multidisciplinary cancer clinic at which endoscopic resection was determined to be the preferred
treatment modality. A literature review and approach to patients with nasopharyngeal masses will be presented.
Conclusions: Papillary seromucinous adenocarcinoma is a rare tumor that can present in the nasopharynx. We
describe the endoscopic surgical management of one such patient that presented to our care.
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The nasopharynx accounts for less than 1% of malignan-
cies in the United States. The most common malignancy
in the nasopharynx is Nasopharyngeal Carcinoma
(NPC), which is a form of squamous cell carcinoma
(SCC) with a histopathology and behavior unique from
SCC originating elsewhere in the head and neck [1].
However, the differential diagnosis for a nasopharyngeal
mass remains broad. Benign lesions include but are not
limited to juvenile nasal angiofibroma, thornwaldt’s
cysts, papillomas, craniopharyngiomas and benign saliv-
ary gland tumors. In addition to NPC, chordomas,
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the nasopharynx.
A common problem with nasopharyngeal malignancies
is that patients can often present without local symp-
toms; rather their primary tumor will be detected during
the workup of a metastasis to a cervical lymph node [2].
Tumors of the nasopharynx can present with a common
set of complaints, generally due to non-specific local
effects of the neoplasm. Nasal obstruction may result
from mass effects and tumor bleeding can lead to epistaxis
or hemoptysis. If the tumor obstructs the Eustachian tube,
the patient may develop a middle ear effusion with result-
ant conductive hearing loss and/or tinnitus. Some patients
can present with headaches, otalgia or cranial nerve defi-
cits. The most frequently affected cranial nerves are cra-
nial nerves III, V, VI and XII [3].
We present the case of a 64-year-old woman with a
rare nasopharyngeal malignancy of salivary origin, that
being papillary serous adenocarcinoma.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 2 T1-weighted coronal MRI image demonstrating
thickening of the right Eustachian tube orifice (arrow). The
lesion appears limited to the Eustachian tube and nasopharynx,
without invasion of adjacent structures.
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Patient presentation
A 64 year-old woman presented with a 3-year history of
epistaxis and right-sided otitis media with effusion. She
had no history of nasal obstruction, dysphagia, odyno-
phagia, voice change, vision change, diploplia, weight
loss, or B-symptoms. There was no prior history of
smoking or radiation and she had minimal alcohol con-
sumption. Prior to referral she had twice undergone bi-
opsy of the lesion and this was first reported as a benign
growth in the nasopharynx. A third biopsy was then
diagnosed as a low-grade seromucinous papillary carcin-
oma, for which she was referred to our center for defini-
tive management.
Physical examination of the patient was remarkable for
a right-sided tympanostomy tube and 0.5-1 cm lesion
derived from the right Eustachian tube. The lesion had a
fleshy papillomatous appearance. Examination of cranial
nerves III-VII and IX-XII was unremarkable as was
examination of the oral cavity. The patient had no palp-
able lymphadenopathy (Figure 1).
A CT scan of the head and neck had been performed.
The scan was normal in appearance with notable absence
of bony erosion or involvement of adjacent structures.
There was no cervical adenopathy. MRI demonstrated
thickening of the right Eustachian tube orifice and con-
firmed that it did not involve adjacent structures such as
the parapharyngeal space (Figure 2).
Surgical technique
The patient was assessed by a Multidisciplinary Head &
Neck Oncology team, wherein primary surgery via endo-
scopic resection was deemed the best first-line treat-
ment. This decision was made in consideration of the
small size and minimal growth of the tumor over a 3-
year period, its pedunculated nature, the absence of
involvement of surrounding structures and patient pre-
ference to avoid chemoradiation or more invasive open
surgical approaches. For access to the lesion, a corridorFigure 1 Left: Transnasal endoscopic view of the nasopharynx demon
eustacian tube and entering the nasopharynx. Right: Intraoperative pho
remnant of the lumen of the Eustachian tube.was created in the nasal cavity, including development
of binasal access via posterior septectomy. The tumor
was visualized at its origin at the Eustachian tube orifice.
The resection began with dissection of the mucosa cov-
ering the face of the sphenoid. This developed a superior
plane to provide access to the tumor and expose the
pterygoid wedge. The wedge was followed inferolaterally
to expose the skull base, pterygoid wedge and medial
pterygoid plate. The plate mucosa was stripped for an
anterior tumor margin.
A linear cut was made in the posterior aspect of the
torus tubarius anterior to the fossa of Rosenmuller to es-
tablish a posterior margin. The levator palatini muscle
was incised inferiorly where it joined into the torus
tubarius for an inferior margin. All soft tissue over thestrating a pedunculated lesion originating from the right
to of the deep aspect of the resection. The suction is pointing to the
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ial pterygoid muscle, forming the lateral resection mar-
gin boundary. We then used careful cautery to form
deep cuts, peeling tumor off the underlying surface of
the skull base until we came to our posterior cut. The
depth of dissection was approximately to the bony isth-
mus of the Eustachian tube. The specimen was friable
and so it was removed as 2 large pieces. Frozen sections
were deemed to be impractical. The surgical margins
were at the level of the petrous carotid and pterygoid
plates, and the tumor appeared to be completely
removed at a gross level.
Pathologic findings
Final pathology was performed on the two resected frag-
ments. The medial fragment consisted of reactive re-
spiratory muscosa with chronic inflammation, abundant
fibrinous hemorrhage and necrosis; no viable tumor was
seen. The deeper specimen contained fragments of a
well-differentiated papillary neoplasm consistent with
low grade papillary seromucinous adenocarcinoma, as
previously diagnosed, the histology having been com-
pared to that of the previous biopsy (Figure 3).
Follow-up
An MRI was performed 6 months post-operatively to
reevaluate the operative site. There was no evidence of a
lesion in the right Eustachian tube or nasopharynx. She was
seen in clinic the following week. She had no symptoms of
recurrence and the nasopharyngeal mucosa and EustachianFigure 3 Low power hematoxylin and eosin staining demonstrates w
fibrinous hemorrhage. Mucin was demonstrated by special staining (nottube orifice were unremarkable on nasopharyngoscope.
There was no cervical lymphadenopathy. The patient will
be followed with serial physical examination and MRI to
monitor for recurrence.Discussion
Salivary gland tumors account for less than 5% of head
and neck neoplasms and typically present in the oral
cavity [4]. The likelihood of finding malignant rather
than benign disease in a salivary gland tumor increases
as the size of the gland of origin decreases [5]. Salivary
gland carcinoma accounts for less than 0.5% of all naso-
pharyngeal malignancies, likely owing to the low density
of salivary gland tissue in the nasopharynx. Within the
nasopharynx, adenoid cystic carcinoma is the most com-
mon salivary gland tumor, followed by adenocarcinoma [6].
Papillary serous adenocarcinoma is a histologically
unique form of adenocarcinoma. This tumor is consid-
ered to be derived from nasopharyngeal surface epithe-
lium rather than from underlying minor salivary glands,
based on histological appearance and immunohisto-
chemical staining profile. It is uncommon, occurring
over a wide age range with no sex predilection. The
commonest site is lateral or posterior wall or roof of the
nasopharynx, and it presents as a soft to gritty mass with
a nodular or papillary appearance. Despite a benign
histological appearance, this tumor is infiltrative and
tends to recur if not completely removed.
While major salivary gland tumors have their own sta-
ging system, minor salivary gland tumors are stagedell differentiated papillary epithelial fragments, embedded in
shown).
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ging Manual classifies the T stage of nasopharyngeal
tumors based on the presence or absence of involvement
of surrounding structures such as the parapharyngeal
space, skull base, paranasal sinus, cranial nerves, hypo-
harynx, orbit, infratemporal fossa or masticator space
[7]. Like other cancers, N or nodal staging and M or me-
tastasis staging are also important in the prognostication
and treatment of these tumors. Our case presented as a
T1N0M0 lesion given the absence of involvement of sur-
rounding structures, lymph nodes or distance metastasis.
Multiple treatment modalities exist for the treatment
of salivary gland tumors of the nasopharynx [8]. Generally
low-grade salivary gland tumors are less radiosensitive than
their high-grade counterpart [9]. The traditional thera-
peutic approach for patients with high-grade or unresect-
able (T4) disease is radiotherapy. A surgical approach is
more appropriate for low-grade, low-stage adenocarcin-
omas. While the 5-year disease survival of patients with
adenocarcinoma of the nasopharynx is approximately 65%,
non-randomized studies demonstrate a survival benefit
with the involvement of a surgical approach [10].
To our knowledge endoscopic resection of nasopha-
ryngeal salivary gland tumors is not yet a common prac-
tice. Since the majority of patients with nasopharyngeal
malignancies present with spread to cervical lymph
nodes and/or the parapharyngeal space, less invasive
techniques may not be considered. Primary endoscopic
approaches to other nasopharyngeal neoplasms have
been described with increasing frequency. Localized be-
nign lesions such as juvenile nasal angiofibromas can be
endoscopically resected, typically after angioembolization
[11,12]. Furthermore, while open surgical approaches have
been the traditionally favored surgical modality for local
control, there are now reports of endoscopic resection to
address local recurrence of nasopharyngeal carcinoma
[13,14]. For other malignancies, such as localized chon-
droid cordoma of the nasoppharynx and skull base, some
authors advocate strongly for the use of endoscopic resec-
tion as it spares the morbidity of open approaches [15,16].
There is a paucity of literature that specifically pertains
to the endoscopic resection of exocrine gland neoplasms
of the nasopharynx, particularly as a primary therapy
modality. Al-Sheibani et al. described their 4-handed
endoscopic endonasal transpterygoid nasopharyngect-
omy in a retrospective study of twenty patients. Most
patients in this study had advanced or recurrent disease.
Among other tumors, 5 adenoid cystic and 2 adenocar-
cinomas were described with disease-related mortality
rate of 20% and 50% respectively at the time of publica-
tion [17].
The low staging of our patient’s disease factored into
our decision to pursue endoscopic resection. The ab-
sence of parapharyngeal extension or invasion of adjacentstructures made the approach possible. Furthermore, the
pedunculated nature of the lesion facilitated resection in
that it made the tumor readily distinguishable from sur-
rounding tissue. We were confident based on imaging and
our exam findings that we would not only be able to resect
the tumor but too achieve sufficient normal tissue margins
with an endoscopic approach. Another factor favoring this
approach was the indolent nature of this tumor, progres-
sing minimally over a 3-year period. Our patient will re-
quire close surveillance and while we are confident that
our resection was adequate, if the tumor recurs it should
be detectable by physical examination.
Conclusions
This case is interesting because it represents a rare
pathological variant of an uncommon nasopharyngeal
tumor. Additionally, from our review of the literature,
minor salivary gland tumors of the nasopharynx appear
to be derived from the mucosa of the nasopharynx itself.
However, in the case of our patient, the lesion in ques-
tion was in fact a pedunculated lesion that appeared to
originate from within the Eustachian tube. Finally, the
management of patients such as ours remains controver-
sial. Traditionally surgical resection of nasopharyngeal
malignancies has been performed by an open approach,
but this paradigm appears to be evolving. In this case, a
minimally invasive resection was achieved with no evi-
dence of residual disease. This was made possible by the
small size of the lesion and the lack of invasion of sur-
rounding structures.
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